Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1994-10-13
1997-05-27
Kight, John
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
424 149, 424 165, 534 10, 534 14, 530311, 540450, 564368, A61K 5100, A61M 3614
Patent
active
056329695
ABSTRACT:
Novel N.sub.3 S.sub.2 chelating ligands can be chelated to a radiodetectable element, Tc or Re, and are useful for radiolabeling peptides. A group of peptides especially useful are somatostatin derivatives which are valuable of the selective detection or treatment of tumors with somatostatin receptors.
REFERENCES:
patent: 4837303 (1989-06-01), Jung
patent: 4986979 (1991-01-01), Morgan et al.
patent: 5071636 (1991-12-01), Yamauchi et al.
patent: 5101041 (1992-03-01), Troutner et al.
patent: 5395608 (1995-03-01), Troutner et al.
patent: 5405601 (1995-04-01), Dunn et al.
patent: 5443815 (1995-08-01), Dean et al.
patent: 5556939 (1996-09-01), Flanagan et al.
Serratrice et al (1994), J. Chim. Phys., vol. 91, pp. 753-760 "Paramagnetic Copper (II) and Diamagnetic Copper (I) Complexes with N.sub.3 S.sub.2 and N.sub.2 S.sub.2 Ligands: an EPR and .sup.1 H NMR Study".
DeWanjer (1990), Seminars in Nuclear Medicine, vol. 20, No. 1, pp. 5-27, "The Chemistry of 99m-Tc-Labeled Radio Pharmaceuticals".
Biniakiewicz et al (1992), J. Med. Chem., vol. 35, pp. 274-279 "A New, General Synthetic Route to Multidentate N.sub.1 S Ligands for Use in Technetium-99m Radio-Pharmaceuticals, Preparation of Diamido Disulfur, Diamino Dithiol, and Tripodal N.sub.3 S.sub.3 Prototypes. Comparative Biodistributions of [99m Tc.sup.v O-DADS].sup.- Analgos Which Contain 5,5,5- and 5,7,5-Membered Chelate Ring Systems".
John et al. (1993), Nucl. Med. Bio., vol. 20, No. 2, pp. 217-213, "Synthesis and Biological Evaluation of Gallium Polyaminothiols (PAT)".
Lawrence et al (1991), Aust. J. Chem, vol. 44, pp. 113-121, Quinquedentate Coordination of 6-Methyl-1,1,1-Dithia-4,8-Diazacyclotetradecan-6-Amine to Cobalt (III). X-ray Crystal Structure of the [Co(N.sub.3 S.sub.2)(OOCH.sub.3)] (ClO.sub.4).sub.2 -H.sub.2 O Complex.
Kallert and Mattes (1991), Inorganica Chimica Acta, vol. 180, pp. 263-269, "Xray Crystals Structures of the Copper (II), Nickel (II), and Silver (I) Complexes of a 17-Membered Dibenzo Macrocycle With a N.sub.3 S.sub.2 Donor Set".
Gimarc (1985), Inorganic Chimica Acta, vol. 102, pp. 105-112, "Sulfur-Nitrogen Rings: Relative Stabilities and Structures".
Reubi, J.C., et al., Cancer Research, 47, pp. 5758-5764, Nov. 1, 1987.
Spanevello, R.A., et al., Tetra. Letters, vol. 32, pp. 4675-4678, 1991.
Holum, "Elements of General, Organic, and Biological Chemistry", 9th Edition, p. 257. 1994.
Dufour Jean-Marc
Flanagan Richard J.
Hogan Keith T.
Jones Dameron L.
Kight John
Merck & Co. , Inc.
Rose David L.
Thies J. Eric
LandOfFree
N.sub.3 S.sub.2 chelating ligands optionally radiolabelled with does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N.sub.3 S.sub.2 chelating ligands optionally radiolabelled with , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N.sub.3 S.sub.2 chelating ligands optionally radiolabelled with will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2327085